from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0286/PPE4

LFCtreatmentdescriptionclass of inhibitor

-1.353

Amikacinug/mL Amikacintranslation

-1.083

Cap5-10ug/mL Capreomycintranslation

-2.004

Rox10-50 ug/mL Roxithromycintranslation

-0.070

SM2-5 ug/mL Streptomycintranslation

-1.430

Tet5-10 ug/mL Tetracyclinetranslation

-0.371

Rif0.2-5ug/mL Rifampicintranscription

-0.187

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.626

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.122

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.301

CPZ10-50 ug/mL Chlorpromazinerespiration

2.405

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.092

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.846

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.405

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.223

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.275

Econazole10-24 ug/mL Econazole (azole drug)respiration

2.375

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.502

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.287

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.479

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.614

KCN5-20 ug/mL Potassium cyaniderespiration

-0.405

NaN30.2-2 mM Sodium aziderespiration

-0.286

Nigericin50 uM Nigericinrespiration

0.126

TRC10-150 ug/mL Triclosanrespiration

-0.511

TRZ10-25 ug/mL Thioridazinerespiration

-0.578

Valinomycin0.5-10 uM Valinomycinrespiration

-1.571

ZnSO42 mM ZnSO4respiration

-1.128

menadione6-10 ug/mL Menadionerespiration

2.201

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

1.249

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

2.291

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.602

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.231

NRP_1Non-replicating persistence stage 1dosRassociated

0.636

Amp0.2mg/mL AmpicillincellWall

0.288

Cephalexin20-100 ug/mL CephalexincellWall

0.170

Cerulenin0.32-5 ug/mL CerulenincellWall

0.307

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.407

EMB10-20 ug/mL EthambutolcellWall

0.127

Eta12-40 ug/mL EthionamidecellWall

0.305

INH0.2-0.4 ug/mL IsoniazidcellWall

0.228

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.333

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.328

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.095

BZA0.12 mg/mL BenzamidearomaticAmides

0.115

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.147

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.332

H2O24 mM hydrogen peroxideDNAdamaging

-1.013

Levo10 ug/mL LevofloxacinDNAdamaging

0.364

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.837

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.470

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.257

UVUV-irradiationDNAdamaging

-0.407

ARP41-4 ug/mL Antitubercular compound ARP4?

0.016

Antimycin12.5-50 ug/mL Antimycin A?

-0.261

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.304

PA_110-50 ug/mL Antitubercular compound PA-1?

0.334

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.444

PA8240.2-2 ug/mL PA-824?

-1.152

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.598

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.009

Verapamil50 uM Verapamil?

-0.189

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.384

methoxatin10-20 ug/mL Methoxatin?